- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
OmniAb Inc (OABI)
OmniAb Inc stock price live, this page displays NASDAQ OABI stock exchange data. View the OABI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the OmniAb Inc real time stock price chart below.
What Is the OmniAb Inc Stock Price Today?
The OmniAb Inc stock price today is 1.960.
What Is the Stock Symbol for OmniAb Inc?
The stock symbol for OmniAb Inc is ""OABI.""
What Stock Exchange Does OmniAb Inc Trade On?
OmniAb Inc is listed and trades on the NASDAQ stock exchange.
Is OmniAb Inc a Good Stock to Buy?
Determining whether OmniAb Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OABI quote. (ISIN: US68218J1034)
What Is the OmniAb Inc Stock Price Today?
The OmniAb Inc stock price today is 1.960.
What Is the Stock Symbol for OmniAb Inc?
The stock symbol for OmniAb Inc is ""OABI.""
What Stock Exchange Does OmniAb Inc Trade On?
OmniAb Inc is listed and trades on the NASDAQ stock exchange.
Is OmniAb Inc a Good Stock to Buy?
Determining whether OmniAb Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OABI quote. (ISIN: US68218J1034)
1.960
-0.080(-3.92%)
Real-time Data·
Fair Value
An estimate of a OmniAb's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.955
2.080
52 wk Range
1.220
4.870
OABI Scorecard
Full Analysis
2 analysts have revised their earnings upwards for the upcoming period
OABI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a OmniAb's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.9552.080
52 wk Range
1.2204.870
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OABI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a OmniAb's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
8.250
Upside
+320.92%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
OmniAb Inc Company Profile
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company’s technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners’ drug development efforts. Its OmniAb platform’s Biological Intelligence powers the immune systems of its proprietary and engineered transgenic animals to create optimized antibody candidates for human therapeutics. The company's animal-based technologies include OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences; OmniFlic, a bispecific rat and OmniClic, a bispecific chicken are designed for discovery of bispecific antibody applications; OmniTaur, which provides cow-inspired antibodies with unique structural characteristics for challenging targets; OmnidAb, an in vivo platform for the discovery of single-domain antibodies based upon a human VH scaffold; and OmniDeep, a suite of in silico, an artificial intelligence (AI) and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. The company has an agreement with mAbsolve Ltd. for its Fc-silencing platform technology to incorporate the STR technology into antibodies that have been generated using OmniAb’s antibody discovery platform. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.
OmniAb Inc SWOT Analysis
Antibody Innovation | OmniAb's specialized platform in antibody discovery technology positions it uniquely in the biotech sector, with growing partnerships and a substantial milestone backlog |
Financial Resilience | Despite revenue variability, OmniAb maintains a strong cash position and effective OpEx management, with analyst price targets ranging from $7 to $12 |
Market Differentiation | Explore how OmniAb's pure-play focus and expanding partnerships set it apart in the competitive antibody discovery market, defying common sector headwinds |
Future Catalysts | Delve into OmniAb's anticipated program readouts in 2024-2025, potential for new collaborations, and the company's path to profitability with reduced cash burn |
OmniAb Inc Earnings Call Summary for Q1/2025
- Q1 2025 revenue up to $4.2M from $3.8M YoY; net loss improved to $18.2M from $19M
- Operating expenses projected to decrease to $85-90M, down from previous $90-95M range
- 2025 revenue guidance set at $20-25M; company doubled active partners to 95
- Stock declined 1.27% in aftermarket trading; InvestingPro analysis suggests undervaluation
- CEO expresses confidence in 2025 trajectory, emphasizing value creation and long-term profitability
Last Updated: 08/05/2025, 22:36
Read Full TranscriptCompare OABI to Peers and Sector
Metrics to compare | OABI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOABIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.9x | −3.5x | −0.5x | |
PEG Ratio | −0.60 | 0.06 | 0.00 | |
Price/Book | 0.9x | 1.6x | 2.6x | |
Price / LTM Sales | 9.0x | 2.2x | 3.3x | |
Upside (Analyst Target) | 390.2% | 92.4% | 42.8% | |
Fair Value Upside | Unlock | 13.3% | 6.5% | Unlock |
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 8.250
(+320.92% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-0.17 / -0.14
Revenue / Forecast
4.15M / --
People Also Watch
FAQ
What Stock Exchange Does OmniAb Trade On?
OmniAb is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for OmniAb?
The stock symbol for OmniAb is "OABI."
What Is the OmniAb Market Cap?
As of today, OmniAb market cap is 249.56M.
What Is OmniAb's Earnings Per Share (TTM)?
The OmniAb EPS (TTM) is -0.59.
From a Technical Analysis Perspective, Is OABI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has OmniAb Stock Split?
OmniAb has split 0 times.
How Many Employees Does OmniAb Have?
OmniAb has 114 employees.
What is the current trading status of OmniAb (OABI)?
As of 06 Aug 2025, OmniAb (OABI) is trading at a price of 1.96, with a previous close of 2.04. The stock has fluctuated within a day range of 1.96 to 2.08, while its 52-week range spans from 1.22 to 4.87.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.